What's new

Human medicines European public assessment report (EPAR): Iclusig, ponatinib, Date of authorisation: 01/07/2013, Revision: 26, Status: Authorised

Human medicines European public assessment report (EPAR): Iclusig, ponatinib, Date of authorisation: 01/07/2013, Revision: 26, Status: Authorised

Feb 18, 2025 - 17:06
 0
Human medicines European public assessment report (EPAR): Iclusig, ponatinib, Date of authorisation: 01/07/2013, Revision: 26, Status: Authorised
Human medicines European public assessment report (EPAR): Iclusig, ponatinib, Date of authorisation: 01/07/2013, Revision: 26, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Ebvallo, tabelecleucel...

Next Article

UN Shipping Body’s Green Fuels Law Could Worsen the Sector’s Climate Impact — Study

Related Posts

European medicines agencies network strategy (EMANS) to 2028 webinar, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 13 February 2025, 13:00 (CET) to 13 February 2025, 17:00 (CET)

European medicines agencies network strategy (EMANS) to...

Feb 18, 2025  0

EMEA-002713-PIP02-21-M01

EMEA-002713-PIP02-21-M01

Feb 17, 2025  0

EMEA-003499-PIP01-23

EMEA-003499-PIP01-23

Feb 13, 2025  0